Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.
about
Chemotherapy for advanced non-small cell lung cancer in the elderly populationSecond or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseSecond or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseChemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)Quality of Life in elderly patients with cancerAlbumin-bound paclitaxel in solid tumors: clinical development and future directionsImpact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study.First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II studyCombination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study.Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis.Carboplatin and gemcitabine in first-line treatment of elderly patients with advanced non-small cell lung cancer: data from a retrospective study.Evaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small-cell lung cancer.[A meta analysis of doublets versus single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer].Doublet versus single cytotoxic agent as first-line treatment for elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis.A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer.Doublets versus single-agent therapy as first-line therapy for elderly patients with advanced non-small cell lung cancer? A systematic review of randomised controlled trials.Phase I study of carboplatin combined with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer.Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer.Treatment of advanced non small cell lung cancer in routine care: a retrospective analysis of 212 consecutive patients treated in a community based oncology group practiceEpidermal growth factor receptor tyrosine kinase inhibitors for elderly patients with advanced non-small cell lung cancer.Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509.The association of transporter genes polymorphisms and lung cancer chemotherapy responseCustomizing systemic therapy in patients with advanced non-small cell lung cancer.Pharmacological factors influencing anticancer drug selection in the elderly.Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba.3',4',5',5,7-pentamethoxyflavone sensitizes Cisplatin-resistant A549 cells to Cisplatin by inhibition of Nrf2 pathwayGemcitabine Plus Platinum Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Analysis.Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors.Five years managing metastatic non-small cell lung cancer: experience at a teaching hospital.Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib.Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung CancerPaclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840.Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).Three-dimensional conformal radiotherapy by delineations on CT-based simulation in different respiratory phases for the treatment of senile patients with non-small cell lung cancerErlotinib plus capecitabine as first-line treatment for older Chinese patients with advanced adenocarcinoma of the lung (C-TONG0807): an open-label, single arm, multicenter phase II study.Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnaireTherapeutic options in older patients with metastatic non-small cell lung cancer.State of the art in therapy for non-small cell lung cancer.Treatment of elderly cancer patients with chemotherapy.
P2860
Q24186466-B340C645-DC60-472B-9633-05F0E597A800Q24200518-CBF778A4-2697-4282-BC31-38E0B20AF4B0Q24243664-70B33F78-E886-4624-BDC0-F07FF25173FFQ24792196-DBEFE386-1AC1-4F9E-9FD3-9B51970D05BFQ24802727-6AFCEABA-B9D1-4452-B63C-0A910956B1A1Q26798674-780AC9B2-EC28-4AED-94BD-CF1D65709583Q30275205-812EE53D-988D-4903-BCB6-F32D4776238BQ33378383-68A87C77-EE2B-467C-BDFC-9883810FB744Q33379206-661E598F-6090-45AA-9E7F-927AEA6C3B7DQ33383403-866A062C-B253-4EE9-8D00-C35DA90BBDE2Q33396438-6390D36A-EEC5-40FB-ADBF-007E882C51C5Q33398466-DE045159-4DE3-4947-B01D-AF081D06C5CEQ33401712-46134F1B-2E6C-4DED-B31A-D478EE45CB1AQ33401852-70BE8698-65DE-4111-AFDA-131EDAF8F8B7Q33409548-8ECBDE3B-3D4A-4419-ABEB-671D09D65366Q33411167-CD0F7741-8704-4188-B6DB-A4E25E290CC1Q33414360-FE418BBC-21F9-416F-BF39-4E2EFB27BA61Q33429178-9D46CAF4-FB34-4ADB-B1E2-2BC5E7A2154EQ33860259-DF4F33DF-1469-4936-9270-68D9EFE749B0Q34001991-9E8C38BB-26B3-4FF3-8756-ED54F7D87BA8Q34121219-5C51D2C7-AC0C-44FA-8CF0-342745617A3AQ34786733-ED522D14-2FFF-4D2C-84DA-D3A03E3D559BQ35124361-5AA72BBB-7877-4ADB-B2E3-06B780CA4A33Q35146940-1CF05618-D6A6-4664-A7EE-11005B42003EQ35182963-300DD86B-A591-41CB-BC60-FA480111D31BQ35262406-27A77118-CF7F-4018-A231-5425EE9E4AE4Q35644451-0C2BF65E-E944-41D3-BDC3-AC6AEB59F0F5Q35661049-09511517-88BD-4469-9FA2-88DF257F85C2Q35771257-1BFBB8F0-C522-48BB-A346-CE4C09AD1212Q35866141-32D38CC0-6089-4593-B4B2-229674423BA8Q35875986-1C943195-9E46-4B41-A280-B41301EB7E04Q35877754-0B2924D7-BB68-4E4E-9BD1-49B662D39044Q35902810-D2D7D90F-277E-48A7-B331-5FC2F6069AD4Q35980560-6B499029-09DD-4646-BCC4-3E9967DFDFF0Q36068373-92A7096A-4EB9-4356-B694-7678615738D7Q36151475-5763BD0B-130B-460C-86AC-5CC1F9C4199DQ36160569-46FD79A9-31C4-4249-AE39-328815B3A1F9Q36180083-D31D70EC-AFCC-4BDF-BB37-1B17CBC49D0CQ36271949-78F35FC6-EED2-499E-B34F-54BE7B442E1DQ36276360-E058C4B2-2919-4EDB-BB57-42B16AC9AAEF
P2860
Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Cisplatin-based therapy for el ...... roup 5592, a randomized trial.
@en
Cisplatin-based therapy for el ...... roup 5592, a randomized trial.
@nl
type
label
Cisplatin-based therapy for el ...... roup 5592, a randomized trial.
@en
Cisplatin-based therapy for el ...... roup 5592, a randomized trial.
@nl
prefLabel
Cisplatin-based therapy for el ...... roup 5592, a randomized trial.
@en
Cisplatin-based therapy for el ...... roup 5592, a randomized trial.
@nl
P2093
P356
P1476
Cisplatin-based therapy for el ...... roup 5592, a randomized trial.
@en
P2093
Corey J Langer
David H Johnson
John W Kugler
Judith Manola
Patricia Bernardo
Philip Bonomi
P304
P356
10.1093/JNCI/94.3.173
P407
P50
P577
2002-02-01T00:00:00Z